deltatrials
Unknown Status PHASE2_PHASE3 Interventional NCT00194337

Digital Mammography, Ultrasound, MRI, and PET Scans in Women With Newly Diagnosed Breast Cancer

Evaluation of Multimodality Breast Imaging: Project 3-Lesion Staging

Sponsor: Abramson Cancer Center of the University of Pennsylvania

Conditions Breast Cancer
Interventions breast imaging study comparison of screening methods fludeoxyglucose F 18 magnetic resonance imaging positron emission tomography radiomammography ultrasound imaging
Updated 4 times since 2017 Last updated: Mar 12, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2_PHASE3 trial investigates Breast Cancer and is currently ongoing. Abramson Cancer Center of the University of Pennsylvania leads this study, which shows 4 recorded versions since 2026 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotUnknown Status~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshotUnknown Status~Apr 2019 – present · 88 months · monthly snapshotUnknown Status

Change History

4 versions recorded

  1. Apr 2019 — Present [monthly]

    Unknown Status PHASE2_PHASE3

  2. Jun 2018 — Apr 2019 [monthly]

    Unknown Status PHASE2_PHASE3

  3. Feb 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2_PHASE3

    Status: Completed → Unknown Status

  4. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2_PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Abramson Cancer Center of the University of Pennsylvania
  • National Cancer Institute (NCI)
Data source: Abramson Cancer Center of the University of Pennsylvania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations